Key points are not available for this paper at this time.
Prophylactic cranial irradiation reduces the incidence of symptomatic brain metastases and prolongs disease-free and overall survival. (ClinicalTrials.gov number, NCT00016211 ClinicalTrials.gov.).
Slotman et al. (Wed,) studied this question.